AC
VRCA icon

Armistice Capital’s Verrica Pharmaceuticals VRCA Stock Holding History

Armistice Capital’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Sell
426,304
-91,877
-18% -$573K 0.03% 158
2026
Q1 		$2.74M Sell
518,181
-600,744
-54% -$3.85M 0.05% 146
2025
Q4 		$9.3M Buy
1,118,925
+479,732
+75% +$2.66M 0.11% 105
2025
Q3 		$2.75M Sell
639,193
-248,941
-28% -$1.5M 0.04% 137
2025
Q2 		$4.71M Buy
888,134
+31,394
+4% +$169K 0.08% 101
2025
Q1 		$3.79M Sell
856,740
-35,360
-4% -$229K 0.06% 125
2024
Q4 		$6.24M Buy
+892,100
New +$9.81M 0.09% 117

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Armistice Capital's VRCA Position: Q2 2026 in Review

Armistice Capital reduced its Verrica Pharmaceuticals (VRCA) stake by 18% in Q2 2026, selling an estimated $573K and leaving 426,304 shares worth $2.61M. The position accounts for 0.03% of the portfolio, ranked #158.

Armistice Capital first reported a position in VRCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.3M in Q4 2025. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Armistice Capital held 426,304 shares of Verrica Pharmaceuticals worth $2.61M as of Q2 2026.
  • Armistice Capital sold 91,877 Verrica Pharmaceuticals shares in Q2 2026, an estimated $573K.
  • Verrica Pharmaceuticals made up 0.03% of Armistice Capital's portfolio in Q2 2026, its #158 holding.
  • Armistice Capital first reported a position in Verrica Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Armistice Capital's Verrica Pharmaceuticals position peaked at $9.3M in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.